Vaxcyte, Inc.
PCVX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Vaxcyte, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 188 | 2 | 197 | +11 |
| Shares | 84.1M | 18.6K | 100.1M | +16.0M (+19.0%) |
| Value | $3.15B | $698.8K | $5.00B | +$1.84B (+58.5%) |
2 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (37)
Institutions that held Vaxcyte, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (26)
Institutions that held Vaxcyte, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Carlyle Group Inc. | 1,923,158 | $72.1M |
| TPG GP A, LLC | 1,190,336 | $44.6M |
| Citadel Advisors LLC | 854,110 | $32.0M |
| Vivo Capital, LLC | 579,508 | $21.7M |
| Deerfield Management Company, L.P. (Series C) | 295,000 | $11.1M |
| Two Sigma Investments, LP | 238,398 | $8.94M |
| Jump Financial, LLC | 105,800 | $3.97M |
| Sphera Funds Management Ltd. | 90,000 | $3.37M |
| SG Americas Securities, LLC | 50,626 | $1.90M |
| Altium Capital Management LP | 43,000 | $1.61M |
| Two Sigma Advisers, LP | 39,500 | $1.48M |
| Cubist Systematic Strategies, LLC | 30,308 | $1.14M |
| Man Group plc | – | $955.4K |
| Renaissance Capital LLC | 23,688 | $887.8K |
| HRT Financial LP | 21,688 | $812.0K |
| Caption Management, LLC | 13,110 | $491.4K |
| Candriam Luxembourg S.C.A. | 12,070 | $416.4K |
| Seven Eight Capital, LP | 9,636 | $361.2K |
| UBS Oconnor LLC | 8,071 | $302.5K |
| Fox Run Management, L.L.C. | 6,768 | $253.7K |
| Cutler Group LP | 3,000 | $112.0K |
| BIT Capital GmbH | 2,100 | $78.7K |
| Point72 Middle East FZE | 694 | $26.0K |
| TCI Wealth Advisors, Inc. | 258 | $9.67K |
| Belpointe Asset Management LLC | 148 | $5.55K |
| Ellevest, Inc. | 45 | $1.69K |
Not filed for Q2 2023 yet (2)
Institutions that held Vaxcyte, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| ETF Managers Group, LLC | 18,630 | $698.3K |
| Harvest Group Wealth Management, LLC | 14 | $525 |